Answers are grounded in this paper and cite their sources.
PURPOSE: This study assesses the impact of Advance Directives (ADs) on end-of-life costs, drawing on administrative data from a single health care organization located in Milwaukee, Wisconsin (Independent Care Health Plan, or iCare). BACKGROUND: As part of ongoing Medicaid and Medicare rate reform efforts, greater use of ADs among plans and providers is being considered to better control costs and enhance health outcomes. APPROACH: Drawing on decedent-member descriptive and cost data, OLS regression is used to analyze the relationship between AD use and subsequent costs for a single health care plan. RESULTS: The analysis does not provide evidence of a significant relationship between AD use and end-of-life costs when patient health is controlled for the sample. CONCLUSIONS: There was no evidence within the iCare data to support a relationship between the presence of ADs and lower end-of-life costs.
No takes yet. Share an insight, caveat, or question.
Fonk et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: